Treatment of Fistulizing Perianal Crohn's Disease by Autologous Microfat Enriched With Adipose-Derived Regenerative Cells

Inflamm Bowel Dis. 2022 Jun 3;28(6):967-970. doi: 10.1093/ibd/izab276.

Authors

Karam Matlub Sørensen^{1

2}, Charlotte Harken Jensen^{2

3}, Søren Paludan Sheikh^{2

3}, Niels Qvist^{1

2}, Jens Ahm Sørensen^{2

4}

Affiliations

¹ Research Unit for Surgery and IBD Care, Odense University Hospital, Odense, Denmark.
² Clinical Institute, University of Southern Denmark, Odense, Denmark.
³ Laboratory of Molecular and Cellular Cardiology, Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.
⁴ Research Unit for Plastic Surgery, Odense University Hospital, Odense, Denmark.

PMID: 34791256
DOI: 10.1093/ibd/izab276

No abstract available

Keywords: Crohn’s disease; cell therapy; rectal fistula; stem cells.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Crohn Disease* / complications
Crohn Disease* / therapy
Humans
Mesenchymal Stem Cell Transplantation*
Rectal Fistula* / etiology
Rectal Fistula* / therapy
Transplantation, Autologous
Treatment Outcome